{"id":12165,"date":"2025-03-13T19:59:54","date_gmt":"2025-03-13T18:59:54","guid":{"rendered":"https:\/\/valintermed.com\/?p=12165"},"modified":"2025-03-13T19:59:54","modified_gmt":"2025-03-13T18:59:54","slug":"sindrom-meyera-gorlina","status":"publish","type":"post","link":"https:\/\/valintermed.com\/en\/medlibrary\/meyer-gorlina-syndrome\/","title":{"rendered":"Meyer-Gorlin syndrome"},"content":{"rendered":"
<\/div>\n

Meyer-Gorlin syndrome, also known as G-1 deficiency syndrome, is a rare genetic disorder characterized by abnormal development of various tissues, tissues, and organs based on inherited mutations. This disorder is characterized by a complex of heterogeneous manifestations, including but not limited to transient developmental anomalies that may affect various body systems. Clinical manifestations of the syndrome range from mild to severe, including joint underdevelopment, skeletal abnormalities, and various heart defects. Genetic predisposition is crucial to understanding the pathology, as the disease is often inherited. Meyer-Gorlin syndrome requires a comprehensive approach to diagnosis and treatment, which includes both pharmacological and non-pharmacological strategies.<\/p>\n

\n
\n

Content<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n